APA (7th ed.) Citation

Gordon, C. J., Tchesnokov, E. P., Woolner, E., Perry, J. K., Feng, J. Y., Porter, D. P., & Götte, M. (2020). Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. The Journal of biological chemistry, 295(20), 6785-6797. https://doi.org/10.1074/jbc.RA120.013679

Chicago Style (17th ed.) Citation

Gordon, Calvin J., Egor P. Tchesnokov, Emma Woolner, Jason K. Perry, Joy Y. Feng, Danielle P. Porter, and Matthias Götte. "Remdesivir Is a Direct-acting Antiviral That Inhibits RNA-dependent RNA Polymerase from Severe Acute Respiratory Syndrome Coronavirus 2 with High Potency." The Journal of Biological Chemistry 295, no. 20 (2020): 6785-6797. https://doi.org/10.1074/jbc.RA120.013679.

MLA (9th ed.) Citation

Gordon, Calvin J., et al. "Remdesivir Is a Direct-acting Antiviral That Inhibits RNA-dependent RNA Polymerase from Severe Acute Respiratory Syndrome Coronavirus 2 with High Potency." The Journal of Biological Chemistry, vol. 295, no. 20, 2020, pp. 6785-6797, https://doi.org/10.1074/jbc.RA120.013679.